HeimMEHCQ • OTCMKTS
add
23andMe Holding Co
Við síðustu lokun
4,24 $
Dagbil
4,05 $ - 4,39 $
Árabil
0,47 $ - 10,81 $
Markaðsvirði
117,60 m. USD
Meðalmagn
575,71 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
OTCMKTS
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 45,15 m. | -29,49% |
Rekstrarkostnaður | 65,51 m. | -34,62% |
Nettótekjur | -99,35 m. | 52,43% |
Hagnaðarhlutfall | -220,04 | 32,54% |
Hagnaður á hvern hlut | — | — |
EBITDA | -45,06 m. | 35,08% |
Virkt skatthlutfall | 0,00% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 38,25 m. | -82,33% |
Heildareignir | 159,89 m. | -59,54% |
Heildarskuldir | 186,64 m. | -9,68% |
Eigið fé alls | -26,74 m. | — |
Útistandandi hlutabréf | 27,54 m. | — |
Eiginfjárgengi | -4,37 | — |
Arðsemi eigna | -54,88% | — |
Ávöxtun eigin fjár | -230,70% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | -99,35 m. | 52,43% |
Handbært fé frá rekstri | -40,73 m. | -57,97% |
Reiðufé frá fjárfestingum | -734,00 þ. | 65,80% |
Reiðufé frá fjármögnun | -529,00 þ. | -126,45% |
Breyting á handbæru fé | -41,99 m. | -61,95% |
Frjálst peningaflæði | -82,91 m. | -285,64% |
Um
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Stofnsett
apr. 2006
Höfuðstöðvar
Vefsvæði
Starfsfólk
261
